PATENT CLAIM ANALYSIS

Application Number: 16040405
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "217000"]

Abstract:
The invention provides compositions and methods of treating autism. Specifically, the invention relates to treating the core symptoms of autism by administering α-methyl-DL-tyrosine.

Claim (Index 16):
The method of  claim 15 , wherein said psychometric test is based on clinical global impression (CGI) rating scale, Vineland adoptive behavior scale (VABS), autism diagnostic observation schedule (ADOS), social responsiveness scale (SRS), aberrant behavior checklist-community (ABC-C), repetitive behavior scale (RBS), Conners parent rating scale (CPRS), or a combination thereof.

Metadata:
- Claim Count in Document: 74.0
- Percentile: 95.0
- Lexical Diversity: 1.3
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15524334', '15029596', '15059602', '14415978', '13945384']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7427203379396545
- 35 USC 102 Novelty (BERT): 0.5277552077152545
- Combined Prediction Score: 0.7212238249172146
- Mean Citation Score: 254.371296
- Max Citation Score: 299.7217
- Similarity Product: 193.97112699811456

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test